Print this page
-
Phase 2 Study of INCMGA00012 and the Oncolytic Virus Pelareorep in Metastatic Triple Negative Breast Cancer.
Protocol: 042001Principal Investigator:
- Mridula George (Rutgers University)
Applicable Disease Sites: Breast -
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy.
Protocol: 042201Principal Investigator:
- Mridula George (Rutgers University)
Applicable Disease Sites: Breast -
Awareness, Attitudes, and Apprehensions About Breast Cancer Among South Asians Living in the U.S.
Protocol: 132013Principal Investigator:
- Jaya Satagopan PhD (School of Public Health)
Applicable Disease Sites: Breast -
Evaluation of Depression and Anxiety in Breast Cancer Patients Using Validated Questionnaires.
Protocol: 042105Principal Investigator:
- Bruce Haffty MD (Rutgers University)
Applicable Disease Sites: Breast -
Cancer Analytics and South Asian Health Breast Cancer Survivor Study (CANSAH-BC).
Protocol: 132204Principal Investigator:
- Jaya Satagopan PhD (School of Public Health)
Applicable Disease Sites: Breast -
Pragmatic Phase III Randomized Trial of Proton vs Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation.
Protocol: 041511Principal Investigator:
- Bruce Haffty MD (Rutgers University)
Applicable Disease Sites: Breast - Female
Breast - Male